1,2,3-三氟-5-异硫氰酸基苯 | 362690-52-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,2,3-三氟-5-异硫氰酸基苯
• 中文别名: 3,4,5-三氟异硫氰酸酯
• 英文名称: 3,4,5-trifluorophenyl isothiocyanate
• 英文别名: 1,2,3-trifluoro-5-isothiocyanato-benzene；1,2,3-trifluoro-5-isothiocyanatobenzene
• CAS: 362690-52-6
• 化学式: C₇H₂F₃NS
• 分子量: 189.161
• InChiKey: KFBSFEHVBOTTSM-UHFFFAOYSA-N

物化性质

• 沸点：
  237.0±35.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  1,2,3-三氟-5-异硫氰酸基苯 在 肼基甲酸叔丁酯 、 盐酸 作用下， 以 水 为溶剂， 生成 4-(3',4',5'-trifluorophenyl)-3-thiosemicarbazide
  参考文献：
  名称：

  Synthesis and Structure–Activity Evaluation of Isatin-β-thiosemicarbazones with Improved Selective Activity toward Multidrug-Resistant Cells Expressing P-Glycoprotein

  摘要：

  Cancer multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transporters presents a significant unresolved clinical challenge. One strategy to resolve MDR is to develop compounds that selectively kill cells overexpressing the efflux transporter P-glycoprotein (MDR1, P-gp, ABCB1). We have previously reported structure-activity studies based around the lead compound NSC73306 (1, 1-isatin-4-(4'-methoxyphenyl)-3-thiosemicarbazone, 4.3-fold selective). Here we sought to extend this work on MDR1-selective analogues by establishing whether 1 showed "robust" activity against a range of cell lines expressing P-gp. We further aimed to synthesize and test analogues with varied substitution at the N4-position, and substitution around the N4-phenyl ring of isatin-beta-thiosemicarbazones (IBTs), to identify compounds with increased MDR1-selectivity. Compound 1 demonstrated MDR1-selectivity against all P-gp-expressing cell lines examined. This selectivity was reversed by inhibitors of P-gp ATPase activity. Structural variation at the 4'-phenyl position of 1 yielded compounds of greater MDR1-selectivity. Two of these analogues, 1-isatin-4-(4'-nitrophenyl)-3-thiosemicarbazone (22, 8.3-fold selective) and 1-isatin-4-(4'-tert-butyl phenyl)-3-thiosemicarbazone (32, 14.8-fold selective), were selected for further testing and were found to retain the activity profile of 1. These compounds are the most active IBTs identified to date.

  DOI：

  10.1021/jm2006047
• 作为产物：
  描述：

  3,4,5-三氟苯胺 、 二甲氨基硫代甲酰氯 以 甲苯 为溶剂， 反应 3.0h， 生成 1,2,3-三氟-5-异硫氰酸基苯
  参考文献：
  名称：

  吡唑并嘧啶：针对鼻和肠病毒衣壳的有效抑制剂。

  摘要：

  当前尚无可用于治疗由肠病毒（EV）引起的急性和慢性疾病的药物，例如普通感冒，脑膜炎，脑炎，肺炎和心肌炎，伴或不伴连续性扩张性心肌病。在这里，我们报告吡唑并嘧啶的发现和表征，吡唑并嘧啶是一类耐受性强且有效的新型EV抑制剂。化合物抑制EV的体外广谱与IC的复制50值之间的0.04和0.64μ中号适用于对pleconaril（一种已知的衣壳结合抑制剂）有抗性的病毒，而不会影响细胞色素P450酶的活性。使用病毒学和遗传学方法，病毒衣壳被确定为最有希望的，口服生物利用的化合物3-（4-三氟甲基苯基）氨基-6-苯基吡唑并[3,4- d ]嘧啶-4-胺（OBR-5 ）的靶标-340）。柯萨奇病毒B3引起的小鼠慢性心肌炎的预防性和治疗性应用都得到了证明。小鼠体内良好的药代动力学，毒理学和药效学特征使OBR-5340成为高度有前途的候选药物，并且正在进行非临床监管计划。

  DOI：

  10.1002/cmdc.201500304

文献信息

• [EN] TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5<br/>[FR] MODULATEURS TÉTRAHYDRO-BENZOIMIDAZOLYLES DE TGR5
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2015160772A1

  公开（公告）日：2015-10-22

  The present invention comprises compounds of Formula (I). wherein: R1, R2, R3, R4, R5, R6, R7, R8, X, Z1and Z2 are defined in the specification.

  本发明包括式（I）的化合物。其中：R1、R2、R3、R4、R5、R6、R7、R8、X、Z1和Z2在规范中定义。
• 1, 3, 4 -OXADIAZOLE DERIVATIVES AS DGAT1 INHIBITORS
  申请人：Johnstone Craig

  公开号：US20100029727A1

  公开（公告）日：2010-02-04

  Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, wherein: n is 1, 2 or 3 and each R is independently selected from fluoro, chloro, cyano, methyl, ethyl, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy and difluoromethoxy; together with processes for their preparation, pharmaceutical compositions containing them and their use as medicaments.

  提供化学式（I）的化合物或其盐，其抑制乙酰辅酶A（乙酰辅酶A）：二酰基甘油酰基转移酶（DGAT1）活性，其中：n为1、2或3，每个R独立地选择自氟、氯、氰、甲基、乙基、甲氧基、乙氧基、三氟甲基、三氟甲氧基和二氟甲氧基。同时提供其制备过程、含有它们的制药组合物及其作为药物的用途。
• COMPOUNDS FOR THE INHIBITION OF DGAT1 ACTIVITY
  申请人：Bennett Stuart Norman Lile

  公开号：US20100173958A1

  公开（公告）日：2010-07-08

  Compounds of formula (I), or salts thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, wherein, for example, R 1 is optionally substituted phenyl or naphthyl; Ring A is selected from (3-6C)cycloalkyl, (5-12C)bicycloalkyl and phenyl; n is 0, 1 or 2; R 2 is, for example, hydrogen, fluoro, chloro or hydroxy; Ring B is selected from (3-6C)cycloalkyl, (5-12C)bicycloalkyl and phenyl; L 1 is a direct bond or a defined linker group and R 3 is, for example, hydroxy, carboxy or (1-6C)alkoxycarbonyl; together with processes for their preparation, pharmaceutical compositions containing them and their use as medicaments.

  提供了化学式为（I）的化合物或其盐，其能够抑制乙酰辅酶A：二酰基甘油酰基转移酶（DGAT1）的活性。其中，例如，R1是可选的取代苯基或萘基；环A选自（3-6C）环烷基，（5-12C）双环烷基和苯基；n为0、1或2；R2是，例如，氢、氟、氯或羟基；环B选自（3-6C）环烷基，（5-12C）双环烷基和苯基；L1是直接键或定义的连接基，R3是，例如，羟基，羧基或（1-6C）烷氧羰基；还提供了制备它们的过程，含有它们的药物组合物以及它们作为药物的用途。
• Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
  作者：David A. McLeod、Mathias Kirk Thøgersen、Casper Larsen Barløse、Mette Louise Skipper、Erlaitz Basabe Obregón、Karl Anker Jørgensen

  DOI：10.1002/anie.202206096

  日期：2022.7.18

  A non-covalent organocatalytic enantioselective (8+3) cycloaddition of donor–acceptor cyclopropanes and heptafulvenoids is reported. The reaction design employs an anionic cyclopropane activation strategy by employing a bifunctional optically-active Brønsted base. The reaction pathway and mechanism of stereochemical control was investigated by DFT calculations.

  报道了供体-受体环丙烷和七黄黄酮的非共价有机催化对映选择性 (8+3) 环加成反应。该反应设计采用双功能光学活性布朗斯特碱的阴离子环丙烷活化策略。通过DFT计算研究了立体化学控制的反应途径和机制。
• Tetrahydro-benzoimidazolyl modulators of TGR5
  申请人：Janssen Pharmaceutica NV

  公开号：US10077241B2

  公开（公告）日：2018-09-18

  The present invention comprises compounds of Formula (I). wherein: R1, R2, R3, R4, R5, R6, R7, R8, X, Z1 and Z2 are defined in the specification.

  本发明包括式（I）化合物。 其中 R1、R2、R3、R4、R5、R6、R7、R8、X、Z1 和 Z2 的定义见说明书。